Cargando…
The Rational Design of Specific Peptide Inhibitor against p38α MAPK at Allosteric-Site: A Therapeutic Modality for HNSCC
p38α is a significant target for drug designing against cancer. The overproduction of p38α MAPK promotes tumorigenesis in head and neck squamous cell carcinoma (HNSCC). The ATP binding and an allosteric site referred as DFG are the key sites of the p38α mitogen activated protein kinase (MAPK) exploi...
Autores principales: | Gill, Kamaldeep, Nigam, Lokesh, Singh, Ratnakar, Kumar, Suresh, Subbarao, Naidu, Chauhan, Shyam Singh, Dey, Sharmistha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077802/ https://www.ncbi.nlm.nih.gov/pubmed/24983631 http://dx.doi.org/10.1371/journal.pone.0101525 |
Ejemplares similares
-
Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
por: Sahu, Vishal, et al.
Publicado: (2019) -
Structure Based Design and Synthesis of Peptide Inhibitor of Human LOX-12: In Vitro and In Vivo Analysis of a Novel Therapeutic Agent for Breast Cancer
por: Singh, Abhay kumar, et al.
Publicado: (2012) -
Antifungal and Antiproliferative Protein from Cicer arietinum: A Bioactive Compound against Emerging Pathogens
por: Kumar, Suresh, et al.
Publicado: (2014) -
PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation
por: Liu, Chao, et al.
Publicado: (2023) -
Rational design of allosteric switchable catalysts
por: Pan, Tiezheng, et al.
Publicado: (2022)